Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Enalaprilat Market by Type (1mL Vial, 2mL Vial), By Application (Hospital, Pharmacy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Enalaprilat Market by Type (1mL Vial, 2mL Vial), By Application (Hospital, Pharmacy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 241082 4200 Pharma & Healthcare 377 225 Pages 4.9 (33)
                                          

Market Overview:


The global enalaprilat market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of hypertension and other cardiovascular diseases, rising demand for generic drugs, and growing awareness about the benefits of enalaprilat. By type, the global enalaprilat market is segmented into 1mL vials and 2mL vials. The 1mL vial segment is expected to account for a larger share of the market than the 2mL vial segment during the forecast period. By application, hospital pharmacies are expected to account for a larger share of the global enalaprilat market than retail pharmacies duringthe forecast period.


Global Enalaprilat Industry Outlook


Product Definition:


Enalaprilat is a drug used to treat high blood pressure and heart failure. It belongs to a class of drugs called ACE inhibitors.


1mL Vial:


1mL Vial is used for the storage of medications and contains about 0.09 mg of active ingredient. It is a type of pharmaceutical vial that is used to store various types of injectable drugs, including anticoagulants, anti-epileptics, antibiotics (erythromycin), antivirals (acyclovir), anesthetics & sedatives among others.


2mL Vial:


2mL Vial is used for the packaging of Enalaprilat. It is a clear, sterile solution containing the active pharmaceutical ingredient (API), which is used to treat hypertension and heart failure. The 2 mL vials are available with either a plastic or glass container and come in different colors that help differentiate them from other products in the market.


The 2 mL vials are widely accepted by hospitals, clinics,.


Application Insights:


The application segment includes hospital and pharmacy. Enalaprilat is most commonly used in the treatment of heart failure, hypertension, and renal impairment. In 2017, the heart failure segment dominated the global market owing to a high prevalence of this condition coupled with growing awareness about effective management of cardiovascular diseases among population across the globe.


In terms of revenue, the hospital application segment accounted for USD 142.3 million in 2017 due to increasing usage as an anti-clotting agent during surgeries and emergency treatment procedures related to blood disorders such as pulmonary embolism (PE) & deep vein thrombosis (DVT).


Regional Analysis:


North America was the largest regional market in 2017 owing to high demand for blood pressure lowering medicines. The region will retain its dominant position throughout the forecast years on account of rising incidence of hypertension coupled with increasing awareness about available drugs. In addition, presence of a large number of manufacturers in this region will help sustain the price level over coming years.


Asia Pacific is expected to be one of fastest growing regions during the forecast period due to factors such as improving healthcare infrastructure and economic development in emerging countries like China and India. Moreover, these countries are also majorly known for their low cost production which makes them an attractive place for pharmaceutical companies looking to set up manufacturing facilities at affordable costs. This is likely to have a positive impact on overall APE market growth over next few years.


Growth Factors:


  • Increasing prevalence of hypertension and other heart diseases
  • Growing awareness about the benefits of Enalaprilat therapy
  • Rising demand for better and more effective treatment options for hypertension and heart diseases
  • Technological advancements in the field of cardiac care that are increasing the adoption of Enalaprilat therapy 5. Availability of generic versions of Enalaprilat that are making it more affordable for patients

Scope Of The Report

Report Attributes

Report Details

Report Title

Enalaprilat Market Research Report

By Type

1mL Vial, 2mL Vial

By Application

Hospital, Pharmacy

By Companies

Hikma Pharmaceuticals, Teva(Barr Pharmaceuticals), Novartis(Hexal AG), SteriMax, KRKA, Cadila Pharmaceuticals, Balkan Pharmaceuticals

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

225

Number of Tables & Figures

158

Customization Available

Yes, the report can be customized as per your need.


Global Enalaprilat Market Report Segments:

The global Enalaprilat market is segmented on the basis of:

Types

1mL Vial, 2mL Vial

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Pharmacy

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Hikma Pharmaceuticals
  2. Teva(Barr Pharmaceuticals)
  3. Novartis(Hexal AG)
  4. SteriMax
  5. KRKA
  6. Cadila Pharmaceuticals
  7. Balkan Pharmaceuticals

Global Enalaprilat Market Overview


Highlights of The Enalaprilat Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. 1mL Vial
    2. 2mL Vial
  1. By Application:

    1. Hospital
    2. Pharmacy
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Enalaprilat Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Enalaprilat Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Enalaprilat is a medication used to treat high blood pressure. It works by reducing the amount of blood that flows through your veins.

Some of the major companies in the enalaprilat market are Hikma Pharmaceuticals, Teva(Barr Pharmaceuticals), Novartis(Hexal AG), SteriMax, KRKA, Cadila Pharmaceuticals, Balkan Pharmaceuticals.

The enalaprilat market is expected to grow at a compound annual growth rate of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Enalaprilat Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Enalaprilat Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Enalaprilat Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Enalaprilat Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Enalaprilat Market Size & Forecast, 2018-2028       4.5.1 Enalaprilat Market Size and Y-o-Y Growth       4.5.2 Enalaprilat Market Absolute $ Opportunity

Chapter 5 Global Enalaprilat Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Enalaprilat Market Size Forecast by Type
      5.2.1 1mL Vial
      5.2.2 2mL Vial
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Enalaprilat Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Enalaprilat Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Pharmacy
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Enalaprilat Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Enalaprilat Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Enalaprilat Analysis and Forecast
   9.1 Introduction
   9.2 North America Enalaprilat Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Enalaprilat Market Size Forecast by Type
      9.6.1 1mL Vial
      9.6.2 2mL Vial
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Enalaprilat Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Pharmacy
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Enalaprilat Analysis and Forecast
   10.1 Introduction
   10.2 Europe Enalaprilat Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Enalaprilat Market Size Forecast by Type
      10.6.1 1mL Vial
      10.6.2 2mL Vial
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Enalaprilat Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Pharmacy
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Enalaprilat Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Enalaprilat Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Enalaprilat Market Size Forecast by Type
      11.6.1 1mL Vial
      11.6.2 2mL Vial
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Enalaprilat Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Pharmacy
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Enalaprilat Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Enalaprilat Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Enalaprilat Market Size Forecast by Type
      12.6.1 1mL Vial
      12.6.2 2mL Vial
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Enalaprilat Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Pharmacy
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Enalaprilat Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Enalaprilat Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Enalaprilat Market Size Forecast by Type
      13.6.1 1mL Vial
      13.6.2 2mL Vial
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Enalaprilat Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Pharmacy
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Enalaprilat Market: Competitive Dashboard
   14.2 Global Enalaprilat Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Hikma Pharmaceuticals
      14.3.2 Teva(Barr Pharmaceuticals)
      14.3.3 Novartis(Hexal AG)
      14.3.4 SteriMax
      14.3.5 KRKA
      14.3.6 Cadila Pharmaceuticals
      14.3.7 Balkan Pharmaceuticals

Our Trusted Clients

Contact Us